missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human GRID2IP (aa 823-926) Control Fragment Recombinant Protein
Recombinant Protein
Supplier: Invitrogen™ RP100009
Description
Highest antigen sequence indentity to the following orthologs: Mouse (97%), Rat (97%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-60985 (PA5-60985. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Specifications
A4D2P6 | |
Blocking Assay, Control | |
392862 | |
100 μL | |
Delphilin; GluR-delta2 philic-protein; glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein; glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein 1; glutamate receptor, ionotropic, delta 2-interacting protein 1; Grid2 interacting protein; GRID2IP; L-delphilin | |
GRID2IP | |
Human | |
His-ABP-tag | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
≥5.0 mg/mL | |
1 M urea, PBS with no preservative; pH 7.4 | |
Human GRID2IP (aa 823-926) Control Fragment | |
RUO | |
GRID2IP | |
Unconjugated | |
Recombinant | |
SETSHMSVKRLRWEQVENSEGTIWGQLGEDSDYDKLSDMVKYLDLELHFGTQKPAKPVPGPEPFRKKEVVEILSHKKAYNTSILLAHLKLSPAELRQVLMSMEP | |
E. coli | |
>80% by SDS-PAGE and Coomassie blue staining |